Closed-Loop Delivery Systems for Insulin Therapy

Bradley R.F. Diabetic ketoacidosis and coma. In: Marble A. , White P. , Bradley R.F. , Krall L.P. , eds. Joslin's Diabetes Mellitus, 11th Edition. Philadelphia: Lea and Febiger, 1971; 361–416.

Pirart J. Diabetes mellitus and its degenerative complications: a prospective study of 4400 patients observed between 1947 and 1973. Diabetes Care 1978; 1: 169–88.

Lauritzen T. , Frost-Larsen K. , Larsen H.W. , Deckert T. and The Steno Study Group. Two years experience with continuous subcutaneous insulin infusion in relation to retinopathy and nephropathy. Diabetes 1985; 35: 74–9.

Brinchmann-Hansen O. , Dhal-Jorgensen K. , Hanssen K. , Sandvik L. and The Oslo Study Group. Effects of intensified insulin treatment on various lesions of diabetic retinopathy. Am J Ophthalmol 1985; 100: 644–53.

Gerich J.E. Treatments of diabetes mellitus. In: De Groot L.J. , ed. Endocrinolgy, 2^nd Edition. Philadelphia: WB Saunders Company, 1989.

Pickup J.C. , Keen H. , Viberti G.C. Continuous subcutaneous insulin infusion in the treatment of diabetes mellitus. Diabetes Care 1980; 3: 290–300.

Home P.D. , Pickup J.C. , Keen H. , Alberti KGMM , Parsons J.A. , Binder C. Continuous subcutaneous insulin infusion: comparison of plasma insulin profiles after infusion of bolus injection at the mealtime dose. Metabolism 1981; 30: 439–42.

Massi Benedetti M. , Antonella M.A. , Calabrese G. Influence of different infusion regimens on metabolic control of insulin dependent diabetics treated with continuous subcutaneous insulin infusion. In: Church J. , ed. Diabetes mellitus, schievements and scepticism. Oxford: Oxford University Press, 1984; 181–8.

Skyler J.S. , Lasky I.A. , Skyler D.L. , Robertson E.G. , Mintz D.H. Home blood glucose monitoring as an aid in diabetes management. Diabetes Care 1978; 1: 150–7.

Tattersall R. Home blood glucose monitoring. Diabetologia 1979; 16: 71–4.

Calabrese G. , Bueti A. , Santeusanio F. Continuous subcutaneous insulin infusion treatment in insulin dependent diabetic patients: a comparison with conventional optimized treatment in a long-term study. Diabetes Care 1982; 5: 457–65.

Calabrese G. , Massi Benedetti M. , Garzi P. Six years clinical experience with CSII. In: Brunetti P. , Waldhausl W. , eds. Advanced models for the therapy of insulin-dependent diabetes. New York: Raven Press, 1987; 141–6.

Mirouze J. , Jaffiol C. , Sany C. Enregistrement glycemique nythemeral continuer dans le diabete instable. Rev Fr Endocrinol 1962; 2: 273–8.

Kadish A.H. Automation control of blood sugar. A servomechanism for glucose monitoring and control. Am J Med Electronics 1964; 3: 82–6.

Albisser A.M. , Leibel B.S. , Exart T.G. , Davidovac Z. , Botz C.K. , Zingg W. An artificial endocrine pancreas. Diabetes 1974; 23: 389–96.

Pfeiffer E.F. , Thum C. , Clemens A.H. The artificial beta-cell. A continuous control of blood sugar by external regulation of insulin infusion (Glucose Controlled Insulin Infusion System) Horm Metab Res 1974; 6: 339–42.

Kraegen E.W. , Campbell L.V. , Chia Y.O. , Meier H. , Lazarus L. Control of blood glucose in diabetics using an artificial pancreas. Aust NZ Jour Med 1977; 7: 280–6.

Slama G. , Kelin J.C. , Tardieu M.C. , Tchobroutsky G. Normalisation de la glycemie par pancreas artificial non miniaturisé. Application pendant 24 heures chez 7 diabetiques insulino-dependants. Nouv Presse Med 1977; 6: 2309–15.

Goriya Y. , Kawamori R. , Shichiri M. , Abe H. The development of an artificial beta cell and its application in depancreatized dogs: the physiological restoration of blood glucose homeostasis. Med Progr Technol 1979; 6: 99–108.

Biostator GCIIS, Operating Manual. Miles Lab Inc, Elkhart, Indiana, USA.

Betalike, Operating Manual, Esaote Biomedica, Genova, Italy.

Clemens A.H. , Chang P.H. , Myers R.W. The development of Biostator, a glucose controlled insulin infusion system (GCIIS). In: Kruse-Jarres J.D. , Molnar G.D. , eds. Blood glucose monitoring. Methodology and clinical applications of continuous in vivo glucose analysis. Proceedings of a workshop-conference. Stuttgart: Thieme, 1976; 23–33.

Reboldi G.P. The Betalike: a practictical artificial pancreas? Diabetic Medicine 1988; 5: 402–4.

Fogt E.J. , Dodd L.M. , Jenning E.M. , Clemens A.H. Development and evaluation of a glucose analyzer for a glucose controlled insulin infusion system (Biostator). Clin Chem 1978; 24: 1366.

Updike S.J. , Hicks G.P. The enzyme electrode. Nature 1967; 214: 986–8.

Brunetti P. , Alberti KGMM , Albisser A.M. , Hepp K.D. , Massi Benedetti M. Artificial systems for insulin delivery. New York: Raven Press, 1983.

Schichiri M. , Kawamori R. , Yamasaki Y. , Hanuki N. , Abe H. Wearable artificial endocrine pancreas with needle type glucose sensor. Lancet 1981; ii: 1129–31.

Turner A.P.F. Miniaturised sensors. In: Brunetti P. , Waldhausl W.K. , eds. Advanced models for the therapy of insulin-dependent diabetes. New York: Raven Press, 1987; 229–33.

Higgins I.J. , Lowe C.R. Introduction to the principles and application of biosensors. Phil Trans Royal Soc Lond 1987; B316: 3–11.

Pickup J.C. Biosensors: a clinical perspective. Lancet 1985; ii: 817–20.

Martin M.J. , Wickramasinghe YABD , Newson T.P. , Crowe J.A. Fibre-optics and optical sensors in medicine. Med & Biol Eng & Comput 1987; 25: 597–604.

Ko W.H. Solid state transducer for biomedical application. Trans Am Soc Artif Intern Organs 1986; 23: 689–95.

Guilbeau E.J. , Towe B.C. , Muhelbauer M.J. A potentially implantable thermoelectric sensor for measurement of glucose. Trans Am Soc Artif Inter Organs 1987; 32: 329–35.

Pfeiffer E.M. On the way to automated blood glucose regulation in diabetes: the dark past, the grey present and the rosy future. Diabetologia 1987; 30: 51–65.

Shichiri M. , Kawamori R. , Yamasaki Y. Needle-type glucose sensor and its clinical application. In: Turner A.P.F. , Karube I. , Wilson G.S. , eds. Biosensors: fundamentals and applications. Oxford: Oxford Univ Press, 1987; 409–24.

Churchouse S.J. , Battersby C.M. , Mullen W.H. , Vadgama P.M. Needle enzyme electrode for biological studies. Biosensors 1986; 2: 325–42.

Mullen W.H. , Keedy F.H. , Churchouse S.J. , Vadgama P.M. Glucose enzyme electrode with extended linearity. Anal Chim Acta 1986; 183: 59–66.

Cass A.E.G. , Davis G. , Francis G.D. Ferrocene-mediated enzyme electrode for amperometric determination of glucose. Anal Chem 1984; 56: 667–71.

Cardosi M.F. , Turner A.P.F. The realization of electron transfer from biological molecules to electrodes. In: Turner A.P.F. , Karube I. , Wilson G.S. , eds. Biosensors: fundamentals and applications. Oxford: Oxford Univ Press, 1987; 257–75.

Matthews D.R. , Bown E. , Beck T.W. , Plotkin E. , Gosden E. , Wickham M. An amperometric needle-type glucose sensor tested in rats and man. Diabetic Medicine 1988; 5: 248–52.

Frew J.E. , Hill H.A.O. Electrochemical biosensors. Anal Chem 1987; 59: 933A–44A.

Albery W.J. , Bartlett P.N. , Cass A.E.G. Amperometric enzyme electrodes. Phil Trans Royal Soc Lond 1987; B316: 107–19.

Wolfson S.F. , Tokarsky J.F. , Yao S.J. , Krupper M.A. Glucose concentration at possible sensor tissue implant sites. Diabetes Care 1982; 5: 126–9.

Fisher U. , Ertle R. , Abel P. Assessment of subcutaneous glucose concentration: validation of the wick technique as a reference for implanted electrochemical sensors in normal and diabetic dogs. Diabetologia 1987; 30: 940–5.

Jansson P.A. , Fowelin J. , Smith U. , Lönnoroth P. Characterization by microdialysis of intercellular glucose level in subcutaneous tissue in humans. Am J Physiol 1988; 255: E218–20.

Woodward S.C. How fibroblasts and giant cells encapsulate implants: consideration in design of glucose sensors. Diabetes Care 1982; 5: 278–81.

Atkins W.J. The construction of mediated amperometric biosensors. In: Turner A.P.F. , Karube I. , Wilson G.S. , eds. Biosensors: fundamental and applications. Oxford: Oxford Univ Press, 1987; 276–90.

Bowers L.D. Application of immobilized biocatalysts in chemical analysis. Anal Chem 1986; 58: 513A–30A.

Andrade J.D. Surface and interfacial aspects of biomedical polymers: protein absorption. Vol 2, New York: Plenum Press, 1984.

Anderson J.M. , Miller K.M. Biomaterial biocompatibility and the macrophage. Biomaterials 1984; 5: 5–10.

Guilbeau E.J. , Clark L.C. , Pizziconi V.B. , Schultz J.S. , Towe B.C. Biosensors in artificial organs. Trans Am Soc Artif Intern Organs 1987; 32: 834–7.

Vadgama P.M. Biocompatibility of sensors. In: Brunetti P. , Waldhausl W.K. , eds. Advanced models for the therapy of insulin-dependent diabetes. New York: Raven Press, 1987; 235–9.

Cesar E.Y. , Shultz J.S. Sterilization of biosensors. Trans Am Soc Artif Intern Organs 1987; 32: 840–5.

Clemens A.H. Feedback control dynamics for glucose controlled insulin infusion system. Med Progr Technol 1979; 6: 91–8.

Rizza R.A. , Gerich J.E. , Haymond M.W. Control of blood sugar in insulin dependent diabetes: comparison of an artificial endocrine pancreas, continuous subcutaneous insulin infusion and intensified conventional therapy. N Engl J Med 1980; 303: 1313–8.

Broekhuyse H.M. , Nelson J.D. , Zinman B. , Albisser A.M. Comparison of algorithms for the closed-loop control of blood glucose using the artificial beta cell. IEEE Trans Biomed Eng 1981; BME-28: 678–87.

Cobelli C. , Ruggeri A. Evaluation of portal/peripheral route and of algorithms for insulin delivery in the closed-loop control of glucose in diabetes. A modeling study. IEEE Trans Biomed Eng 1981; BME-30: 93–103.

Calabrese G. , Bueti A. , Zega G. Improvement of artificial endocrine pancreas (Biostator GCIIS) performance combining feedback controlled insulin administration with a pre-programmed insulin infusion. Horm Metab Res 1982; 14: 505–7.

Sorensen J.T. , Colton C.K. , Hillman R.S. , Soeldner J.S. Use of a physiologic pharmacokinetic model of glucose homeostasis for assessment of performance requirements for improved insulin therapies. Diabetes Care 1982; 5: 148–57.

Smith O.J. Close control of loops with dead time. Chem Eng Prog 1957; 53: 217–9.

Cobelli C. , Federspil G. , Pacini G. , Salvan A. , Scandellari C. An integrated mathematical model of the dynamics of blood glucose and its hormonal controllers. Math Biosc 1982; 58: 27–60.

Insel P.A. , Liljenquist J.E. , Tobin J.D. Insulin control of glucose metabolism in man. A new kinetic approach. J Clin Invest 1975; 55: 1057–66.

Reboldi G.P. , Home P.D. , Morris A.J. , Fabietti P.G. , Massi Benedetti M. Design and simulation of a time delay compensator for closed-loop insulin delivery. Proceedings of The 5th International Symposium on Metabolism, May 15-17 1989, Padua (Italy). Rome: CIC Edizioni Internazionali, 1989; 26.

Bellomo G. , Brunetti P. , Calabrese G. , Mazzotti D. , Sarti E. , Vincenzi A. Optimal feedback glycaemia regulation in diabetics. Med & Biol Eng & Comput 1982; 20: 329–35.

Stephanopoulos G. Chemical process control: an introduction to theory and practice. Englewood Cliff: Prentice-Hall International Inc, 1984.

Kondo K. , Sano A. , Kiluchi M. , Sakurai Y. Adaptive and optimal blood glucose control system. Inst MC Symp on “Control systems concepts and approaches to clinical medicine” Sussex, 5-7 April, 1982; 103–6.

Fisher K. , Schenk W. , Salzsieder E. , Albrecht G. , Abel P. , Freyse E.J. Does physiological blood glucose control require an adaptive control strategy? IEEE Trans Biomed Eng 1987; BME-34: 575–81.

Haga E. ed Computer techniques in biomedicine and medicine. Philadelphia: Auerbach Publishers Inc, 1973.

Albisser A.M. , Schulz M. Simulating human intermediary metabolism: OMNI et al. In: Marks V. , Alberti KGMM , eds. Clinical biochemistry nearer the patient. London: Saunders, 1986; 59–67.

Sozzi S. , Strack T. , Schulz M. , Albisser A.M. Compliance in microcomputer-assisted conventional insulin therapy: computer simulation study results. Am J Physiol 1988; 254: E237–42.

Pickup J.C. Rothwell D. Technology and the diabetic patient. Med & Biol Eng & Comput 1984; 22: 385–400.

Blackshear P.J. , Robbins D.C. , Rohde T.D. , Langer R.S. , Moses A.C. , Massey E.H. Insulin replacement: current concepts. Trans Am Soc Artif Intern Organs 1986; 32: 646–55.

Galloway J.A. , Jackson R.L. , Bechtel L.D. Factors influencing the bioavailability of insulin. In: Brunetti P. , Alberti KGMM , Albisser A.M. , Hepp K.D. , Massi Benedetti M. , eds. Artificial systems for insulin delivery. New York: Raven Press, 1983; 75–81.

Shichiri M. , Kawamori R. , Hakui N. , Yamasaki Y. , Abe H. Closed-loop glycaemic control with a wearable artificial endocrine pancreas. Variations in daily insulin requirements to glycaemic response. Diabetes 1984; 33: 1200–2.

Forbes C.D. Thrombosis and artificial surfaces. Clin Haematol 1981; 10: 653–9.

Selam J.L. Closed-loop insulin delivery systems (artificial pancreas) update. In: Krall L.P. , ed. World book of diabetes in practice. Vol 3. Amsterdam: Elsevier Science Publisher BV, 1988; 176–80.

Shade D.S. , Eaton R.P. , Davis T. The kintics of peritoneal insulin absorption. Metabolism 1981; 30: 149–53.

Knutterud G.L. , Fisher M. For the ISGIID investigators: International Study Group on Implantable Insulin Delivery Devices Registry. Diab Nutr Metab 1988; 1: 323–8.

Dodoson G. Insulin surface structure and its interactions. In: Brunetti P. , Waldhäusl W.K. , eds. Advanced models of therapy of insulin-dependent diabetes. New York: Raven Press, 1987; 59–63.

Lougheed W.D. , Woulfe-Flanagan H. , Clement J.R. , Albisser A.M. Insulin aggregation in artificial delivery systems. Diabetologia 1980; 19: 1–9.

Shade D.S. , Eaton R.P. , Delongo J. , Saland L.C. , Ladman A.J. , Carlson G.A. Electron microscopy of insulin precipitates. Diabetes Care 1982; 5: 25–30.

Brange J. , Hansen J.F. , Havelund S. , Melberg S.G. Studies of the insulin fibrillation process. In: Brunetti P. , Waldhäusl W.K. , eds. Advanced models for the therapy of insulin-depend diabetes. New York: Raven Press, 1987; 85–90.

Brownlee M. , Cerami A. , Li J.J. , Vlassara T.R. , Martin T.R. , McAdam KPWJ Association of insulin pump therapy with raised serum amyloid A in type 1 diabetes mellituš. Lancet 1984; i: 411–3.

Selam J.L. , Zirinis P. , Mellet M. , Mirouze J. Stable insulin for delivery systems: in vitro studies with different containers and solvents. Diabetes Care 1987; 10: 343–7.

Feingold V. , Jenkins A.B. , Kraegen E.W. Effect of contact materials on vibration-induced insulin aggregation. Diabetologia 1984; 27: 373–8.

Selam J.L. Towards the implantable artificial pancreas. In: Ensminger W.D. , Selam J.L. , eds. Infusion systems in medicine. Mount Kisco: Futura Publishing Co, 1987; 6: 55–98.